Ana Isabel Álvarez De Felipe-rekin lankidetzan egindako argitalpenak (15)

2008

  1. Fluoroquinolone efflux mediated by ABC transporters

    Journal of Pharmaceutical Sciences, Vol. 97, Núm. 9, pp. 3483-3493

2007

  1. Absorption and metabolism of albendazole after intestinal ischemia/reperfusion

    European Journal of Pharmaceutical Sciences, Vol. 31, Núm. 1, pp. 16-24

  2. Effects of ischemia-reperfusion on the absorption and esterase metabolism of diltiazem in rat intestine

    Life Sciences, Vol. 80, Núm. 5, pp. 397-407

  3. Inhibitory effects of different antioxidants on hyaluronan depolymerization

    Carbohydrate Research, Vol. 342, Núm. 1, pp. 96-102

2006

  1. Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion

    Drug Metabolism and Disposition, Vol. 34, Núm. 4, pp. 690-695

  2. Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): Influence of flavonoids and role in milk secretion in sheep

    Journal of Veterinary Pharmacology and Therapeutics, Vol. 29, Núm. 4, pp. 279-287

  3. Interaction of probenecid with the breast cancer resistance protein transporter (BCRP/ABCG2)

    Letters in Drug Design and Discovery, Vol. 3, Núm. 4, pp. 236-241

  4. Role of ABC transporters in veterinary drug research and parasite resistance

    Current Drug Delivery, Vol. 3, Núm. 2, pp. 199-206

2005

  1. Comparative study of hyaluronic derivatives: Rheological behaviour, mechanical and chemical degradation

    International Journal of Biological Macromolecules, Vol. 35, Núm. 1-2, pp. 63-69

  2. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2)

    Drug Metabolism and Disposition, Vol. 33, Núm. 5, pp. 614-618

2003

  1. Effect of clotrimazole on microsomal metabolism and pharmacokinetics of albendazole

    Journal of Pharmacy and Pharmacology, Vol. 55, Núm. 6, pp. 757-764

  2. Ginseng increases intestinal elimination of albendazole sulfoxide in the rat

    Comparative Biochemistry and Physiology - C Toxicology and Pharmacology, Vol. 136, Núm. 1, pp. 9-15

  3. Improved LC method to determine ivermectin in plasma

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 31, Núm. 4, pp. 639-645

  4. Intestinal elimination of albendazole sulfoxide: Pharmacokinetic effects of inhibitors

    International Journal of Pharmaceutics, Vol. 263, Núm. 1-2, pp. 123-132

  5. Mitochondrial, sarcoplasmic membrane integrity and protein degradation in heart and skeletal muscle in exercised rats

    Comparative Biochemistry and Physiology - C Toxicology and Pharmacology, Vol. 134, Núm. 2, pp. 199-206